Ovarian Cancer Research Samples
11 Results
1 - 11 of 11 total samples.
Advanced Data View:
1 - 11 of 11 total samples.
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test 1 Result | Test 2 | Test 2 Result | Test 3 | Test 3 Result | Product Details | Price | Buy | Stage | Treatment Status | Site of Primary Disease 1 | Specific Diagnosis 1 | Primary/Metastatic | Malignant/Benign | TNM: | Grade | Tumor size/ foci | Tumor content % | Necrosis % | HIV-I/II, Hepatitis B, Hepatitis C Test Results |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07B84ED86D | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 50 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 61 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | III | N/A | Ovary | Serous carcinoma | Primary | Malignant | |||||||||
| 22P9W2SG1V | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 57 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 85 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | III | N/A | Ovary | Serous carcinoma | Metastatic | Malignant | |||||||||
| 71V3F64O6A | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 59 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 70 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | III | N/A | Ovary | Serous carcinoma | Metastatic | Malignant | |||||||||
| AQKJG822F3 | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 71 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 49 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | II | N/A | Ovary | Serous carcinoma | Primary | Malignant | |||||||||
| BF19871378 | Ovarian Cancer | Ukraine | Serum | 1.00 | 3.00 | $450.00 | 45 Y | F | White | <-70C | 26-Sep-24 | Organ | Ovary | Clinical Diagnosis | Ovarian cancer | Pathological Diagnosis | Pseudomucinous adenocarcinoma | $450.00 | II | T2N0M0 | G1 | 2*2,1*1,8 | N/A | N/A | Negative | ||||||||
| F2GT7B4DVM | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 71 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 95 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | III | N/A | Ovary | Serous carcinoma | Primary | Malignant | |||||||||
| F5G8YKU4X3 | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 79 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 64 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | N/A | N/A | Ovary | Sebaceous carcinoma | Primary | Malignant | |||||||||
| KUKQ0UGLY9 | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 50 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 61 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | III | N/A | Ovary | Serous carcinoma | Primary | Malignant | |||||||||
| O9YPGX6W4L | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 66 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 196 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | IV | N/A | Ovary | Serous carcinoma | Primary | Malignant | |||||||||
| OAH1AA93DS | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 35 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 215 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | III | N/A | Ovary | Endometrioid carcinoma | Primary | Malignant | |||||||||
| PCVUGM3ZV3 | Ovarian Cancer | USA | Serum | 1.00 | 1.00 | $300.00 | 70 Y | F | U/A | <-70C | 04-Mar-26 | Ischemic Time | 60 | Consent Status | Consented | Broad Diagnosis | Carcinoma | $300.00 | IV | N/A | Ovary | Serous carcinoma | Metastatic | Malignant |